Legacy studies employing a single treatment course of two infusions seven days apart demonstrated greatest benefit…
NXC-201 treatment continues to demonstrate 100% complete response rate in 6 relapsed/refractory AL amyloidosis patients…
NXC-201 treatment continues to demonstrate 100% complete response rate in 6 relapsed/refractory AL amyloidosis patients…
As previously reported, resmetirom demonstrated improvements in NASH and liver fibrosis on liver biopsies, the…
– Potential FDA approval anticipated in first quarter 2024, assuming the filing is accepted by…
– Recently reported positive six-month immunogenicity data for IVX-121 against RSV; first clinical evidence of…
Anticipates commencing pivotal pharmacokinetic (PK) trial for AQST-109 (epinephrine sublingual film) in second half of…
SAN DIEGO, Jan. 06, 2023 (GLOBE NEWSWIRE) — Recludix Pharma, a leader in platform approaches…
Dextenza® Net Product Revenue in the Fourth Quarter of 2022 is Estimated to be $13.6…
Presentation scheduled for Monday, January 9, 2023 at 9:45 AM PT NEW YORK, Jan. 06,…
Hamsters infected with SARS-COV-2 and then treated with BiondVax’s inhaled anti-COVID-19 nanosized antibodies (NanoAbs) had…
WAYNE, Pa., Jan. 06, 2023 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage…
-Company To Focus on Preserving Cash to Fund Orderly Wind Down of Operations- -Company To…
Report top-line data from UPLIFT registrational trial in mid-2023, submit potential BLA around year end…
Customers will be able to leverage Snowflake’s single, integrated platform to ensure a safe environment…
HONG KONG, Jan 6, 2023 – (ACN Newswire) – The 16th Asian Financial Forum (AFF),…
Family fintech pioneers new interactive financial literacy game to boost money confidence, knowledge, and skills…
SILICON SLOPES, Utah–(BUSINESS WIRE)–Domo (Nasdaq: DOMO) today announced management will present at the 25th Annual…
PHILADELPHIA–(BUSINESS WIRE)–Comcast Corporation today announced Jason S. Armstrong has been promoted to Chief Financial Officer….
PHILADELPHIA–(BUSINESS WIRE)–Glenmede, a leading investment and wealth management firm overseeing more than $40 billion in…